1 – 10 of 34
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Complement dysregulation associated with a genetic variant in factor H-related protein 5 in atypical hemolytic uremic syndrome
(
- Contribution to journal › Article
- 2023
-
Mark
Arginase release in hemolytic uremic syndrome affects the vasculature
2023) 11th VTEC International Symposium on Shiga Toxin (Verocytotoxin) Producing Escherichia coli Infections(
- Contribution to conference › Abstract
-
Mark
Genetic investigation of Nordic patients with complement-mediated kidney diseases
(
- Contribution to journal › Article
-
Mark
Factor B Mutation in Monozygotic Twins Discordant for Atypical Hemolytic Uremic Syndrome
(
- Contribution to journal › Article
- 2022
-
Mark
Apyrase decreases phage induction and Shiga toxin release from E. coli O157:H7 and has a protective effect during infection
(
- Contribution to journal › Article
- 2021
-
Mark
Factor D Inhibition Blocks Complement Activation Induced by Mutant Factor B Associated With Atypical Hemolytic Uremic Syndrome and Membranoproliferative Glomerulonephritis
(
- Contribution to journal › Article
- 2020
-
Mark
Shiga Toxin-Bearing Microvesicles Exert a Cytotoxic Effect on Recipient Cells Only When the Cells Express the Toxin Receptor
(
- Contribution to journal › Article
- 2019
-
Mark
Blockade of the kallikrein-kinin system reduces endothelial complement activation in vascular inflammation
(
- Contribution to journal › Article
-
Mark
Shiga toxin signals via ATP and its effect is blocked by purinergic receptor antagonism
(
- Contribution to journal › Article
- 2018
-
Mark
Aliskiren inhibits renin-mediated complement activation
(
- Contribution to journal › Article